These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6334138)

  • 1. Use of interleukin-2 in patients with acquired immunodeficiency syndrome.
    Lane HC; Siegel JP; Rook AH; Masur H; Gelmann EP; Quinnan GV; Fauci AS
    J Biol Response Mod; 1984 Oct; 3(5):512-6. PubMed ID: 6334138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of immunodeficiency with interleukin-2: initial exploration.
    Mertelsmann R; Welte K; Sternberg C; O'Reilly R; Moore MA; Clarkson BD; Oettgen HF
    J Biol Response Mod; 1984 Oct; 3(5):483-90. PubMed ID: 6334136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of interleukin-2 in humans.
    Lotze MT; Robb RJ; Sharrow SO; Frana LW; Rosenberg SA
    J Biol Response Mod; 1984 Oct; 3(5):475-82. PubMed ID: 6334135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II trial of recombinant interleukin-2 in AIDS/ARC: alterations of phenotypes of peripheral blood mononuclear cells.
    Flad HD; Ernst M; Kern P
    Lymphokine Res; 1986; 5 Suppl 1():S171-6. PubMed ID: 3491258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired immunodeficiency syndrome. Clinical data and immunologic studies on 9 patients examined in Mexico].
    Abud-Mendoza C; Alcocer-Varela J; González-Amaro R; Díaz-Jouanen E; Alarcón-Segovia D
    Rev Invest Clin; 1984; 36(4):311-9. PubMed ID: 6335588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic studies in patients with the acquired immunodeficiency syndrome].
    Alcocer-Varela J; Alarcón-Segovia D
    Rev Invest Clin; 1987; 39 Suppl():19-23. PubMed ID: 3502505
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome.
    Siegel JP; Lane HC; Stocks NI; Quinnan GV; Fauci AS
    J Biol Response Mod; 1985 Dec; 4(6):596-601. PubMed ID: 3910763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7 and IL-15: therapeutic cytokines for immunodeficiency.
    Alpdogan O; van den Brink MR
    Trends Immunol; 2005 Jan; 26(1):56-64. PubMed ID: 15629410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC).
    Ernst M; Kern P; Flad HD; Ulmer AJ
    J Clin Immunol; 1986 Mar; 6(2):170-81. PubMed ID: 2940258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukins.
    Dinarello CA; Mier JW
    Annu Rev Med; 1986; 37():173-8. PubMed ID: 3518604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralymphatic interleukin 2 treatment in patients with acquired immunodeficiency syndrome: preliminary experience in three cases.
    Gramatzki M; Nüsslein H; Burmester GR; Rödl W; Heyder N; Grote W; Monner DA; Mühlradt PF; Kalden JR
    Immunobiology; 1986 Sep; 172(3-5):438-47. PubMed ID: 3100436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Humoral and cellular immunity in uremia].
    Irkeç C; Irkeç M
    Mikrobiyol Bul; 1982 Jul; 16(3):191-5. PubMed ID: 7167069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer.
    Khatri VP; Baiocchi RA; Bernstein ZP; Caligiuri MA
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S129-36. PubMed ID: 9457408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor.
    Carey JT; Lederman MM; Toossi Z; Edmonds K; Hodder S; Calabrese LH; Proffitt MR; Johnson CE; Ellner JJ
    JAMA; 1987 Feb; 257(5):651-5. PubMed ID: 2432287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin 2. How to reconstruct the immune system].
    Agosto M
    Sidahora; 1995; ():24-5. PubMed ID: 11363212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulins in minimal change nephrotic syndrome--a possible defect in T-cell function.
    Rashid H; Skillen AW; Morley AR; Kerr DN
    Bangladesh Med Res Counc Bull; 1982 Jun; 8(1):15-20. PubMed ID: 6983346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
    Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
    Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers.
    Layon J; Idris A; Warzynski M; Sherer R; Brauner D; Patch O; McCulley D; Orris P
    Arch Intern Med; 1984 Jul; 144(7):1376-80. PubMed ID: 6610400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal perfusion of plasma over immobilized protein A in a patient with Kaposi's sarcoma and acquired immunodeficiency.
    Kiprov DD; Lippert R; Jones FR; Lagios MD; Balint JP; Cohen RJ
    J Biol Response Mod; 1984; 3(3):341-6. PubMed ID: 6379118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.